Nantahala Capital Management, LLC Lucid Diagnostics Inc. Transaction History
Nantahala Capital Management, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Nantahala Capital Management, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 126,362 shares of LUCD stock, worth $118,780. This represents 0.01% of its overall portfolio holdings.
Number of Shares
126,362
Previous 126,362
-0.0%
Holding current value
$118,780
Previous $103,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding LUCD
# of Institutions
34Shares Held
2.05MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX726KShares$682,2750.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$527,2600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA204KShares$192,0930.0% of portfolio
-
Ayrton Capital LLC Westport, CT73.9KShares$69,4723.26% of portfolio
-
Lido Advisors, LLC Los Angeles, CA68KShares$63,9350.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $36.3M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...